Phase Bioscience, Inc.

12 articles about Phase Bioscience, Inc.

• 

  Clinical Catch-Up: October 5-9

  10/12/2020

  It was a moderately busy week for clinical trial news. Here’s a look.
• 

  Clinical Catch-Up: October 14-18

  10/21/2019

  Last week was busy for clinical trial news. Here’s a look.

• Phase Bioscience, Inc. Announces Positive Clinical Results with its Once Weekly GLP-1 Analogue, Glymera™ for the Treatment of Hyperglycemia in Patients with Type 2 Diabetes

  11/15/2011

• Craig Rosen, Ph.D., Biopharmaceutical Development Expert, Joins Phase Bioscience, Inc. as Executive Chairman

  10/9/2008

• Phase Bioscience, Inc. Licenses Key Patent Portfolio, Adds Expert in Protein Engineering IP Protection

  9/23/2008

• Leading Protein Engineering Executive Joins Phase Bioscience, Inc. as CEO

  4/15/2008

• Phase Bioscience, Inc. Secures Funding Resources and Laboratory Space

  3/12/2008

• Phase Bioscience, Inc. Announces New Collaboration with Centocor Research And Development, Inc.

  1/3/2008

• Phase Bioscience, Inc. Announces Series B Investment from Johnson & Johnson Development Corporation, Fletcher Spaght Ventures and Hatteras Venture Partners

  10/24/2007

• Phase Bioscience, Inc. Strengthens Management Team

  4/10/2007

• Phase Bioscience, Inc. Announces Investment From Johnson & Johnson Development Corporation

  1/4/2007

• Phase Bioscience, Inc. Announces Licensing Agreement With Duke University

  11/8/2006